Pathalys Pharma Competitors and Similar CompaniesClear all
Pathalys Pharma's competitors and similar companies include Lava Therapeutics, Quellis Biosciences, Design Therapeutics and Eagle Pharmaceuticals.
 Pathalys Pharma Pathalys Pharma is a clinical biopharmaceutical company that provides therapeutics development solutions. |  Lava Therapeutics Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies. |  Quellis Biosciences Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases. |  Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. |  Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. | |
Founding Date | Founding Date 2021 | Founding Date 2016 | Founding Date 2017 | Founding Date 2017 | Founding Date 2007 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Raleigh, US HQ Fujisawa, JP | Locations Utrecht, NL HQ Philadelphia, US | Locations Boston, US HQ | Locations Carlsbad, US HQ | Locations Woodcliff Lake, US HQ Chicago, US |
Employees | Employees 13 | Employees 34 | Employees N/A | Employees 54 | Employees 10813% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 53.4 m | Valuation ($) N/A | Valuation ($) 313.1 m | Valuation ($) 5.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $12m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $316.6m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $85.5m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $12m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit $231.2m (FY, 2022) |
Net income | Net income N/A | Net income ($25.1m) (FY, 2024) | Net income N/A | Net income ($69.8m) (FY, 2025) | Net income $35.6m (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 150m | Total funding raised $ 102.8m | Total funding raised $ 17m | Total funding raised $ 45m | Total funding raised $ 12.3m |
For sources of this data, please see the company profile
View Company Profiles
Lava Therapeutics
HQ
Utrecht, NL
Employees
34
Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies.
View companyQuellis Biosciences
HQ
Boston, US
Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases.
View companyDesign Therapeutics
HQ
Carlsbad, US
Employees
54
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View companyEagle Pharmaceuticals
HQ
Woodcliff Lake, US
Employees
108↑ 13% increase
Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
View company